You are here

lymphoma

Pfizer's blood cancer therapy Adcetris succeeds in late-stage trial

Reuters

Tue, 03/12/24 - 11:08 am

clinical trials

Gilead’s Kite Expands Arcellx Pact with $285M Equity Investment, Upfront Cash

BioSpace

Wed, 11/15/23 - 11:11 am

Gilead Sciences

FDA Puts Innate’s Lymphoma Trials on Partial Hold After Patient Death

BioSpace

Thu, 10/5/23 - 11:45 am

BIO: Caribou tries to 'go where the puck is going' by taking on cell therapy rivals on home ice

Fierce Biotech

Wed, 06/7/23 - 09:40 pm

Caribou Biosciences

Affimed reveals 25% of staff were laid off in April in wake of phase 2 lymphoma fail

Fierce Biotech

Tue, 05/23/23 - 11:22 am

Gilead’s Yescarta extends survival in lymphoma study

BioPharma Dive

Tue, 03/21/23 - 09:53 pm

Gilead Sciences

large B-cell lymphoma

Gossamer pauses enrollment of lymphoma med, citing risk-benefit profile

Fierce Biotech

Sun, 03/19/23 - 01:43 pm

clinical trials

Pfizer to buy Seagen in $43B cancer drug deal

BioPharma Dive

Mon, 03/13/23 - 10:57 am

Cancer drug startup Cargo raises $200M to solve CAR-T relapse

BioPharma Dive

Thu, 03/2/23 - 10:28 am

Cargo Therapeutics

FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate

Endpoints

Sun, 01/8/23 - 09:59 pm

priority review

bispecific antibodies

FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022

BioPharma Dive

Wed, 01/4/23 - 10:11 am

multiple sclerosis

Gilead Sciences

TG Therapeutics

Roche takes over development of Biogen-partnered lymphoma drug

BioPharma Dive

Tue, 12/20/22 - 11:11 am

ASH: Roche touts Lunsumio's durable efficacy as AbbVie, Regeneron plot lymphoma bispecific battle

Fierce Pharma

Mon, 12/12/22 - 10:21 am

With 70% staff gone, Nordic Nanovector board members jump ship amid 'strategic review'

Fierce Biotech

Fri, 09/16/22 - 10:13 am

Nordic Nanovector

FDA lifts partial hold on Curis' lymphoma study — shares spike

Endpoints

Thu, 08/18/22 - 11:08 am

clinical trials

Legend scraps early-stage CAR-T for lymphoma 6 weeks after clinical hold lifted

Fierce Biotech

Fri, 07/8/22 - 10:32 am

clinical trials

Janssen's Imbruvica Demonstrates Significant Survival Outcomes In Older Lymphoma Patients

BioSpace

Mon, 06/6/22 - 10:03 am

clinical trials

ASCO: Seagen, Takeda think Adcetris can become a force as a lymphoma combo drug

Fierce Pharma

Fri, 05/27/22 - 10:31 am

Roche trumpets new glofitamab data in lymphoma at ASCO

Pharmaforum

Fri, 05/27/22 - 10:24 am

bispecific antibodies

CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise

BioSpace

Thu, 05/12/22 - 10:42 pm

CRISPR Therapeutics

clinical trials

Pages